Introducing Room-Temperature Stable Nicorandil Pills by Medkart, Boosting Access to Cardiac Treatment in India

Introducing Room-Temperature Stable Nicorandil Pills by Medkart, Boosting Access to Cardiac Treatment in India

In a continued struggle to alleviate the financial burden of cardiac care in India, Medkart introduces a groundbreaking innovation: the country's first room-temperature stable generic Nicorandil tablets. These tablets have the potential to make heart medication more accessible, affordable, and logistically convenient for millions, by eliminating the need for expensive cold-chain storage.

Medkart, a foremost generic medicine platform in India, has announced the launch of the nation's most sought-after Nicorandil tablets, which remain stable at room temperature. This innovation eradicates the need for costly cold-chain storage, thereby overcoming logistical hurdles and making the medication more affordable and accessible for patients across various regions. The product is now available at all Medkart outlets.

Room-Temperature Nicorandil: Addressing Storage Challenges in Cardiac MedicationsNicorandil is a commonly prescribed medication for the treatment of chronic stable angina. Traditionally, its storage has required stringent cold-chain logistics due to sensitivity to temperature and humidity. This requirement is often a significant challenge, particularly in rural and semi-urban areas where maintaining cold-chain infrastructure is difficult.

Improving Affordability and AccessibilityThe room-temperature stable Nicorandil tablets are manufactured under WHO-GMP-certified facilities, ensuring high-quality standards. Eliminating the need for refrigeration allows Medkart to substantially reduce distribution costs, making the medication priced up to 80% lower compared to its branded counterparts.

"Our room-stable Nicorandil is more than just a product; it's an answer to India's cold chain problem in heart care," said Ankur Agarwal, Co-founder of Medkart. "We're proving that innovation doesn't have to be expensive-it has to be relevant."

Enhancing Treatment Consistency and Saving LivesSenior cardiologist Dr. Ramesh Mehta, based in Ahmedabad, added, "Ensuring that a cardiac drug like Nicorandil remains effective without refrigeration is a major step forward, particularly for patients in remote regions. We've long seen efficacy compromised due to storage issues. This advancement will save lives and improve treatment consistency."

Cardiovascular diseases (CVDs) are a leading cause of mortality in India, according to the Global Burden of Disease Study. Heart disease is the leading cause of death among women in India, accounting for almost 18% of all female deaths. Medkart's launch focuses on addressing both the cost and accessibility challenges related to cardiac care.

Nicorandil 5 MG Tablet

Product AvailabilityMedkart's room-stable Nicorandil tablets are now available at more than 35,000 pin codes and online at www.medkart.in.

5 mg

The following table offers a comparative snapshot of the cost difference between branded and Medkart's generic versions of Nicorandil tablets based on real-time Medkart data:

Rs. 16.5

| Product Type | Strength | Branded Price Per Tab (Rs.) | Medkart Price Per Tab (Rs.) | Savings (Rs.) | Savings (%) || --- | --- | --- | --- | --- | --- || Nicorandil 10 MG Tablet | 10 mg | Rs. 26.95 | Rs. 5.2 | Rs. 21.75 | 80.72% || Nicorandil 5 MG Tablet | 5 mg | Rs. 16.5 | Rs. 3.1 | Rs. 13.4 | 81.21% |

Rs. 3.1

Prices based on current Medkart data. Actual savings may vary.

Rs. 13.4

About MedkartMedkart, founded in 2014, is dedicated to making affordable healthcare accessible for all, particularly for chronic conditions like heart disease, diabetes, and hypertension. With a growing network of over 100 retail outlets across India and a seamless online platform, Medkart empowers people to compare medicine prices, access affordable generics, and receive expert advice from trained pharmacists. To date, Medkart has served over 11 lakh families and facilitated savings of more than Rs. 600 crore. Grounded in transparency and trust, Medkart continues to revolutionize India's pharmaceutical ecosystem by making quality treatment affordable for all.

81.21%

1. This innovation by Medkart, a renowned generic medicine platform, introduces room-temperature stable Nicorandil tablets projected to improve cardiovascular health care in India by eliminating costly cold-chain storage requirements.
2. With these tablets, Medkart aims to enhance treatment consistency for chronic stable angina patients in rural and semi-urban areas, addressing the logistical hurdles often associated with maintaining cold-chain infrastructure.
3. Manufactured under WHO-GMP-certified facilities, the room-temperature stable Nicorandil tablets are priced up to 80% lower compared to their branded counterparts, making them more accessible in personal-finance terms.
4. By reducing the need for refrigeration and substantially decreasing distribution costs, the room-temperature stable Nicorandil tablets embody the interplay of science, technology, and business, demonstrating that innovation in the healthcare domain need not be expensive but rather, should cater to the needs of the people.
5. As cardiovascular diseases account for a significant percentage of mortality in India, particularly among women, this product launch by Medkart underscores their commitment towards addressing the financial and accessibility challenges related to heart care, thereby contributing positively to health-and-wellness and the overall healthcare infrastructure in the country.

Read also: